Sign In

Catherine Lee, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3556 (phone)
catherine.lee@kp.org
Kaiser Permanente Researcher Profiles


​Catherine Lee, PhD, is a biostatistician (research scientist) at the Kaiser Permanente Northern California Division of Research. Her methodological research focuses on the analysis of time-to-event outcomes. She has developed methods for relating sparsely collected time-varying biomarkers of Alzheimer's disease to disease progression, and modeled transplant rejection among leukemia patients who have undergone stem cell transplantation. Dr. Lee's current research includes the development of methods for joint risk prediction using semi-competing risks data. She received a PhD in mathematics from University of California, Los Angeles, and a PhD in biostatistics from Harvard University.

Current Position(s):

  • Research Scientist I

Section Affiliations:

Primary Research Interests:

  • Time-to-event outcomes
  • Risk prediction
  • Semi-competing risks

    No results found matching criteria
    No results found matching criteria

    A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational Diabetes

    Author(s): Badon SE; Zhu Y; Sridhar SB; Xu F; Lee C; Ehrlich SF; Quesenberry CP; Hedderson MM

    J Endocr Soc. 2018 Oct 01;2(10):1158-1169. Epub 2018-09-13.

    PubMed abstract

    ​Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

    Author(s): Brennan BP; Lee C; Elias JA; Crosby JM; Mathes BM; Andre MC; Gironda CM; Pope HG Jr; Jenike MA; Fitzmaurice GM; Hudson JI;

    ​J Psychiatr Res. 2014 Sep;56:98-105. doi: 10.1016/j.jpsychires.2014.05.008. Epub 2014 May 23.

    PubMed abstract

    ​Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

    Author(s): Ringman JM; Elashoff D; Geschwind DH; Welsh BT; Gylys KH; Lee C; Cummings JL; Cole GM

    ​Arch Neurol. 2012 Jun;69(6):757-64. doi: 10.1001/archneurol.2012.277.

    PubMed abstract

    ​Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative

    Author(s): Grill JD; Di L; Lu PH; Lee C; Ringman J; Apostolova LG; Chow N; Kohannim O; Cummings JL; Thompson PM; Elashoff D; Alzheimer's Disease Neuroimaging Initiative

    ​Neurobiol Aging. 2013 Jan;34(1):62-72. doi: 10.1016/j.neurobiolaging.2012.03.006. Epub 2012 Apr 13.

    PubMed abstract

    ​Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas.

    Author(s): Kachroo P; Pak PS; Sandha HS; Lee C; Elashoff D; Nelson SD; Chmielowski B; Selch MT; Cameron RB; Holmes EC; Eilber FC; Lee JM

    ​J Thorac Oncol. 2012 Mar;7(3):552-8. doi: 10.1097/JTO.0b013e31824176df.

    PubMed abstract

    ​Dermatologic care in the homeless and underserved populations: observations from the Venice Family Clinic

    Author(s): Grossberg AL; Carranza D, Lamp; K, Chiu MW; Lee C; Craft N

    ​Cutis. 2012 Jan;89(1):25-32.

    PubMed abstract

    ​The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study

    Author(s): Kern RS; Gold JM; Dickinson D; Green MF; Nuechterlein KH; Baade LE; Keefe RS; Mesholam-Gately RI; Seidman LJ; Lee C; Sugar CA; Marder SR

    ​Schizophr Res. 2011 Mar;126(1-3):124-31. doi: 10.1016/j.schres.2010.11.008. Epub 2010 Dec 14.

    PubMed abstract